| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/25/1999 | CA2300390A1 Human frezzled-like protein |
| 02/25/1999 | CA2300178A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists |
| 02/25/1999 | CA2298543A1 Loading and release of water-insoluble drugs |
| 02/24/1999 | EP0897979A2 Human sdr2 cdna clone |
| 02/24/1999 | EP0703904B1 Pyrimidine cyanoguanidines as k-channel blockers |
| 02/24/1999 | EP0700440B1 Regulator of contact-mediated hemolysin |
| 02/24/1999 | CN1209139A Prodrugs of thrombin inhibitors |
| 02/24/1999 | CN1209063A Vitronection receptor antagonists |
| 02/24/1999 | CN1209062A Naphthyl-substituted benzimidazole derivatives as anticoagulants |
| 02/24/1999 | CN1209061A Hemoregulatory compounds |
| 02/24/1999 | CN1208637A Application of theaflavine for preparing medicine for treating leukopenia disease |
| 02/24/1999 | CN1208636A Application of theaflavine for preparing medicine for treating cerebral infarction |
| 02/23/1999 | US5874573 Cyclic amine derivatives |
| 02/23/1999 | US5874445 (+) -α- (2,3-dimethoxyphenyl)-1-(2-(4-fluorephenyl) ethyl)-4-piepridinemethanol |
| 02/23/1999 | US5874399 Progenitor B cell stimulating factor |
| 02/23/1999 | US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences |
| 02/23/1999 | US5874253 Expression vectors and genetic engineering |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874224 Growth factor receptor binding protein |
| 02/23/1999 | US5874075 Stable protein: phospholipid compositions and methods |
| 02/18/1999 | WO1999007732A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/18/1999 | WO1999007731A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/18/1999 | WO1999007730A1 SELECTIVE FACTOR Xa INHIBITORS CONTAINING A FUSED AZEPINONE STRUCTURE |
| 02/18/1999 | WO1999007400A1 Dietary supplements containing natural ingredients |
| 02/18/1999 | WO1999007390A1 A universally applicable blood plasma |
| 02/18/1999 | CA2300478A1 Selective factor xa inhibitors |
| 02/18/1999 | CA2299612A1 Selective factor xa inhibitors containing a fused azepinone structure |
| 02/18/1999 | CA2299610A1 Selective factor xa inhibitors |
| 02/17/1999 | EP0896824A1 A universally applicable blood plasma |
| 02/17/1999 | CN1208347A Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 02/17/1999 | CN1207913A Application of theachrome in preparing medicine for plateau erythrocytosis |
| 02/16/1999 | US5872130 Quinoline type mevalonoactones |
| 02/16/1999 | US5872099 Administering high molecular weight fraction having higher platelet aggregation activity; treatment of hemophilia a and other blood disorders |
| 02/16/1999 | US5872098 Nematode-extracted anticoagulant protein |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/11/1999 | WO1999006442A1 EPO PRIMARY RESPONSE GENE, EPRG3Spt |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006409A1 Tricyclic vasopressin agonists |
| 02/11/1999 | WO1999006397A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | WO1999006371A1 Heterocyclic derivatives which inhibit factor xa |
| 02/11/1999 | WO1999006354A1 Il-8 receptor antagonists |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | WO1999006070A1 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 02/11/1999 | WO1999006063A1 EPO PRIMARY RESPONSE GENE, EPRG3pt |
| 02/11/1999 | WO1999005920A1 Cooked cereal ingredient-containing products fortified with edta/iron compositions and methods for use |
| 02/11/1999 | DE19729591A1 Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen Agents for the treatment and / or prophylaxis of microcirculation disorders |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/11/1999 | CA2297894A1 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | CA2295945A1 Heterocyclic derivatives which inhibit factor xa |
| 02/11/1999 | CA2294064A1 Il-8 receptor antagonists |
| 02/11/1999 | CA2267559A1 Cooked cereal ingredient-containing products fortified with edta/iron compositions and methods for use |
| 02/11/1999 | CA2244801A1 Suppressory agents against hypercoagulation |
| 02/10/1999 | EP0752878A4 Products comprising substrates capable of enzymatic cross-linking |
| 02/10/1999 | EP0710239B1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/10/1999 | EP0669940B1 Specifically crosslinked hemoglobin with free functionality |
| 02/10/1999 | CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme |
| 02/10/1999 | CN1207741A Synthetic metal-substituted bacteriochlorophyll derivs. and use thereof |
| 02/10/1999 | CN1207315A 'Binuting' medicine for treating hemorrhinia |
| 02/09/1999 | US5869714 Salts with aminoalcohols exhibiting antithrombotic and thrombolytic activities; oral administration for cardiovascular disorders |
| 02/09/1999 | US5869663 Intermediates for neurokinin receptor antagonists |
| 02/09/1999 | US5869637 Human Kallikrein |
| 02/09/1999 | US5869617 High and low molecular weight fractions of von Willebrand Factor and preparations of same |
| 02/09/1999 | US5869610 Isolated polypeptide identified as a cytokine receptor containing extracellular, transmembrane and intracellular domains; prenatal testing and cancer diagnosis |
| 02/09/1999 | US5869516 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 02/09/1999 | US5869511 Isoxazoline compounds as inhibitors of TNF release |
| 02/09/1999 | US5869501 Amidinonaphthyl derivative or salt thereof |
| 02/09/1999 | US5869486 Fused pyrimidines and pyriazines as pharmaceutical compounds |
| 02/09/1999 | US5869485 Treatment of diseases which respond to inhibition of the activity of the protein tyrosine kinase |
| 02/09/1999 | US5869454 Arginine keto-amide enzyme inhibitors |
| 02/09/1999 | US5869451 Activate the thrombopoietin receptor. |
| 02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/09/1999 | US5869050 Administering to patient antibody against b7 antigen and immunosuppressive agent in synergistic mixture; treatment of transplant rejection, graft versus host disease, rheumatoid arthritis |
| 02/09/1999 | CA1340384C Methode d'utilisation de vecteurs d'expression eucaryotes comprenant un amplificateur du virus bk |
| 02/04/1999 | WO1999005144A1 Novel compounds |
| 02/04/1999 | WO1999005143A1 Novel compounds |
| 02/04/1999 | WO1999005142A1 Novel compounds |
| 02/04/1999 | WO1999005124A1 Novel hexahydro-1,4-diazepine derivatives or salts thereof |
| 02/04/1999 | WO1999005107A1 Vitronectin receptor antagonist |
| 02/04/1999 | WO1999004796A1 Fibrinogen receptor antagonists |
| 02/04/1999 | CA2297910A1 Vitronectin receptor antagonist |
| 02/04/1999 | CA2297909A1 Fibrinogen receptor antagonists |
| 02/04/1999 | CA2296648A1 Novel compounds |
| 02/04/1999 | CA2296426A1 Novel compounds |
| 02/04/1999 | CA2289572A1 Novel hexahydro-1,4-diazepine derivatives or salts thereof |
| 02/03/1999 | EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor |
| 02/03/1999 | EP0894807A1 GPIb-LIPID COMPLEX AND USES THEREOF |
| 02/03/1999 | EP0894789A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors |
| 02/03/1999 | EP0894144A2 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 02/03/1999 | EP0894137A1 Novel human myeloid terminal differentiation response gene |
| 02/03/1999 | EP0894088A1 Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds |
| 02/03/1999 | CN1207042A A Pharmaceutical composition for the treatment of autommune diseases |
| 02/03/1999 | CN1206601A Traditional Chinese medicine prescription for tonifying the kidney reinforcing the spleen and nourishing the blood and preparation process |
| 02/03/1999 | CN1206595A Thrombus dissolving Guiluchun |
| 02/03/1999 | CN1041921C Bicyclic fibrinogen antagonists |
| 02/03/1999 | CN1041920C Glycerin derivative and its pharmacological use |
| 02/03/1999 | CN1041919C N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists |
| 02/02/1999 | US5866685 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 02/02/1999 | US5866681 Oligopeptides |
| 02/02/1999 | US5866610 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical as inhibitors of the cellular NA+/H+ exchange or as a diagnostic, and pharmaceutical containing them |